• Markets
    • icon
  • Companies
EZZ · ASX

EZZ Life Science Holdings Ltd. (ASX:EZZ)

AU$0.61

 0.0 (0.0%)
ASX:Live
01/12/2023 10:43:58 AM
HALO Ords HALO Dividend Growth HALO Consensus Value GROWTH AUS ALL-Recommendations +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

EZZ Overview

EZZ Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About EZZ

Website

N/A

Telephone

N/A

Address

104 Derby Street Silverwater, New South Wales (NSW) 2128

Description

EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. It also develops, produces and distributes consumer health products under its own brand, EZZ, to retailers in Australia and New Zealand as well as consumers in China. The company was founded in 2005 & is headquartered in Silverwater, Australia.

EZZ Price Chart

Key Stats

Market Cap

AU$26.05M

PE

10.30

EV/EBITDA

4.3

Dividends Overview

DIV Yield

.8%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.34 - 0.75

Trade Value (12mth)

AU$4,939.00

1 week

0%

1 month

5.17%

YTD

54.43%

1 year

64.86%

All time high

1.425

Key Fundamentals

EPS 3 yr Growth

124.900%

EBITDA Margin

12.90%

Operating Cashflow

$4m

Free Cash Flow Return

30.80%

ROIC

27.80%

Interest Coverage

460.90

Quick Ratio

5.50

Other Data

Shares on Issue (Fully Dilluted)

43m

HALO Sector

Healthcare

Next Company Report Date

27-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

EZZ Announcements

Latest Announcements

Date Announcements

31 August 22

Preliminary Final Report

×

Preliminary Final Report

30 September 22

Full Year Statutory Accounts

×

Full Year Statutory Accounts

30 September 22

FY22 Financial Results Commentary

×

FY22 Financial Results Commentary

30 March 23

EZZ launches Amazon online store and new product releases

×

EZZ launches Amazon online store and new product releases

30 January 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

29 September 23

Annual Report to shareholders

×

Annual Report to shareholders

29 September 23

Corporate Governance Statement

×

Corporate Governance Statement

29 September 23

Appendix 4G

×

Appendix 4G

29 October 21

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 August 23

FY23 (unaudited) Results Presentation

×

FY23 (unaudited) Results Presentation

28 October 21

Annual Report to shareholders

×

Annual Report to shareholders

28 October 21

EZZ Releases FY21 Annual Report to Shareholders

×

EZZ Releases FY21 Annual Report to Shareholders

28 November 23

Chair's Address to Shareholders

×

Chair's Address to Shareholders

28 November 23

Results of Meeting

×

Results of Meeting

28 January 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

28 February 22

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

28 August 23

Preliminary Final Report

×

Preliminary Final Report

27 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

27 October 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

27 July 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

27 February 23

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

27 April 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

26 July 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

26 April 23

Change of Director's Interest Notice

×

Change of Director's Interest Notice

26 April 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

24 October 23

Final Dividend Announcement

×

Final Dividend Announcement

24 October 23

Dividend/Distribution - EZZ

×

Dividend/Distribution - EZZ

24 October 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

EZZ Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.05 0.03 0.08 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.05 0.03 0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock 27.8 -36.0 175.1 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A 10.3 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A 4.3 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.05 0.04 0.09 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 0.04 0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.5 -27.8 138.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.3 13.1 15.5 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A 0.0 217.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A 0.8 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 9 15 17 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.24 0.27 0.34 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.24 0.27 0.34 Lock Lock Lock
     Growth % Lock Lock Lock Lock 319.1 10.6 28.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 42 43 43 Lock Lock Lock
Basic m Lock Lock Lock Lock 42 43 43 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 22 15 37 Lock Lock Lock
     Growth % Lock Lock Lock Lock 28.7 -32.6 147.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 9 5 23 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 12 6 27 Lock Lock Lock
     Growth % Lock Lock Lock Lock 227.1 -44.3 318.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 52.3 43.2 73.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 48 57 27 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 3 2 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 65.9 -34.7 172.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 12.1 11.7 12.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 3 2 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 73.9 -36.2 181.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 11.5 10.9 12.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 3 2 5 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 1 0 1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 2 1 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 28.0 -35.4 176.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 9.1 8.7 9.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 0 2 4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 5 0 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 0 2 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -91.8 678.3 106.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 2 2 3 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 9 10 14 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 12 14 18 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -9 -10 -13 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 3 3 Lock Lock Lock
Equity $m Lock Lock Lock Lock 10 11 15 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 10 11 15 Lock Lock Lock
     Growth % Lock Lock Lock Lock 319.4 12.7 29.1 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 16.9 9.2 20.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 20.1 11.5 24.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 40.7 15.2 34.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 32.4 12.2 27.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 4.1 17.7 30.8 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 251.0 396.9 460.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -3.3 -5.9 -2.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -86.8 -91.0 -91.6 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.1 5.0 5.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.9 4.8 5.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 75.5 74.9 81.3 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 13.1 67.5 136.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 9.4 6.7 20.2 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 69.9 29.2 17.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.3 1.3 2.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 2.1 3.5 3.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.9 1.1 2.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.9 1.1 2.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 12.3 11.8 13.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 22.7 12.5 27.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 25.8 26.3 25.9 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 16.9 9.2 20.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.3 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 20.1 11.5 24.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 90.7 85.4 83.2 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 18.2 9.8 20.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 5.2 12.5 21.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 38.7 54.5 18.1 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 43.9 67.0 39.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 61.5 21.4 32.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -17.6 45.6 7.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.8%

Franking Level

100%

DPSg

217.78%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EZZ Shortsell

Frequently Asked Questions

The current share price of EZZ Life Science Holdings Ltd. (EZZ:ASX) is AU$0.61.
The 52-week high share price for EZZ Life Science Holdings Ltd. (EZZ:ASX) is AU$0.75.
The 52-week low share price for EZZ Life Science Holdings Ltd. (EZZ:ASX)? is AU$0.34.
The current TTM dividend payout for EZZ Life Science Holdings Ltd. (EZZ:ASX) is 0.80.
The last dividend payment of EZZ Life Science Holdings Ltd. (EZZ:ASX) is AU$0.01.
EZZ Life Science Holdings Ltd. (EZZ:ASX) has a franking level of 100%.
EZZ Life Science Holdings Ltd. (EZZ:ASX) is classified in the Healthcare.
The current P/E ratio for EZZ Life Science Holdings Ltd. (EZZ:ASX) is 10.30.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.